Skip to main content

Advertisement

Anti-Retroviral Therapy (ART) Monitoring and the Development of the Oligonucleotide Ligation Assay for Detecting Critical Drug-resistant Mutations in HIV-2 Patients in Preparation of the Global Fund Initiative in The Gambia

Article metrics

Background

Data on resistance mutations in HIV-2 infected patients are limited. With the Global Fund Initiative a large number of HIV-2 patients will receive ART. It is important to monitor the response of HIV-2 infected patients to ART and to study their resistance profiles. Developing cheaper and more sustainable assays are a priority, especially in resource-poor settings.

Materials and methods

A cohort of 8 treatment-naïve HIV-2 infected patients received ART and was studied longitudinally for about 7 years; clinical, immunological, virological and data were collected. The entire HIV-2 protease and RT was amplified, sequenced and analysed for several time points. An Oligonucleotide Ligation Assay (OLA) was developed for the detection of resistance mutations.

Results

The mutations M184V (7/8), Q151M (1/8), K65R (1/8) mutations were observed. HIV-2 OLA was successfully developed for M184V, a classic Lamivudine mutation and for Q151M, a multi-drug resistance mutation.

Conclusion

We identified important HIV-2 mutations and developed a simple, economical and sustainable HIV-2 OLA for the detection of these resistance mutations.

Author information

Correspondence to Sabelle Jallow.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jallow, S., Kaye, S., Alabi, A. et al. Anti-Retroviral Therapy (ART) Monitoring and the Development of the Oligonucleotide Ligation Assay for Detecting Critical Drug-resistant Mutations in HIV-2 Patients in Preparation of the Global Fund Initiative in The Gambia. Retrovirology 2, S134 (2005) doi:10.1186/1742-4690-2-S1-S134

Download citation

Keywords

  • Infectious Disease
  • Cancer Research
  • Lamivudine
  • Resistance Mutation
  • Resistance Profile